Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,718 | 20,894 | 10,367 | 9,222 | -4,028 |
| Depreciation Amortization | 4,279 | 3,322 | 2,225 | 2,195 | 2,136 |
| Income taxes - deferred | 1,712 | 6,629 | -702 | 2,391 | -2,578 |
| Accounts receivable | 2,052 | -2,572 | -494 | -4,914 | 9,191 |
| Other Working Capital | 19,571 | -14,370 | 1,389 | -14,116 | -5,901 |
| Other Operating Activity | -5,565 | -13,660 | 746 | 5,077 | -8,203 |
| Operating Cash Flow | $24,767 | $243 | $13,531 | $-144 | $-9,383 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,353 | -6,290 | -2,979 | -3,850 | -1,736 |
| Net Acquisitions | N/A | -3,810 | -556 | 2,823 | -925 |
| Investing Cash Flow | $-4,353 | $-10,100 | $-3,535 | $-1,028 | $-2,661 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,781 | 3,245 | -1,058 | 2,864 | 1,287 |
| Debt Issued | N/A | 10,296 | 1,307 | 1,347 | 153 |
| Debt Repayment | -2,343 | -1,486 | -3,884 | -1,082 | -982 |
| Common Stock Issued | 916 | 231 | 587 | 257 | 213 |
| Common Stock Repurchased | N/A | N/A | N/A | -619 | -137 |
| Other Financing Activity | -273 | -933 | -3,202 | 1,498 | 9,506 |
| Financing Cash Flow | $4,081 | $11,353 | $-6,250 | $4,265 | $10,040 |
| Exchange Rate Effect | 4,006 | 2,458 | -395 | -1,490 | -2,754 |
| Beginning Cash Position | 14,876 | 10,922 | 7,571 | 5,968 | 10,233 |
| End Cash Position | 43,377 | 14,876 | 10,922 | 7,570 | 5,968 |
| Net Cash Flow | $28,501 | $3,954 | $3,351 | $1,603 | $-4,265 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,767 | 243 | 13,531 | -144 | -9,383 |
| Capital Expenditure | -4,373 | -6,290 | -3,109 | -3,893 | -2,256 |
| Free Cash Flow | 20,394 | -6,047 | 10,422 | -4,037 | -11,639 |